184 related articles for article (PubMed ID: 7562567)
21. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
[TBL] [Abstract][Full Text] [Related]
22. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK
J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
[TBL] [Abstract][Full Text] [Related]
23. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
24. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
[TBL] [Abstract][Full Text] [Related]
25. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
26. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
[TBL] [Abstract][Full Text] [Related]
27. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
[TBL] [Abstract][Full Text] [Related]
28. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
Mechan AO; O'Shea E; Elliott JM; Colado MI; Green AR
Psychopharmacology (Berl); 2001 Jun; 155(4):413-8. PubMed ID: 11441431
[TBL] [Abstract][Full Text] [Related]
29. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
30. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
31. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
[TBL] [Abstract][Full Text] [Related]
33. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Jaehne EJ; Majumder I; Salem A; Irvine RJ
Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
[TBL] [Abstract][Full Text] [Related]
34. Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats.
Fernandez F; Aguerre S; Mormède P; Chaouloff F
Eur J Neurosci; 2002 Aug; 16(4):607-18. PubMed ID: 12270036
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Piper BJ; Fraiman JB; Owens CB; Ali SF; Meyer JS
Neuropsychopharmacology; 2008 Apr; 33(5):1192-205. PubMed ID: 17609680
[TBL] [Abstract][Full Text] [Related]
36. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
[TBL] [Abstract][Full Text] [Related]
37. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
Colado MI; Granados R; O'Shea E; Esteban B; Green AR
Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
[TBL] [Abstract][Full Text] [Related]
38. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity.
Fone KC; Beckett SR; Topham IA; Swettenham J; Ball M; Maddocks L
Psychopharmacology (Berl); 2002 Feb; 159(4):437-44. PubMed ID: 11823897
[TBL] [Abstract][Full Text] [Related]
39. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
Gudelsky GA; Nash JF
J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
[TBL] [Abstract][Full Text] [Related]
40. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
Malberg JE; Seiden LS
Brain Res; 1997 Aug; 765(1):101-7. PubMed ID: 9310399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
